BioRestorative Therapies, Inc. signed a new employment agreement with Francisco Silva, Vice President of Research and Development and Secretary, effective June 10, 2026. The agreement has an initial term of three years, ending June 10, 2029, with automatic one-year renewals unless notice is provided 90 days in advance. Mr. Silva will continue to receive an annual salary of $575,000. The executive is eligible for a discretionary annual cash bonus of up to 50% of his salary, subject to Board approval. The agreement includes standard restrictive covenants, including non-disclosure, non-solicitation, and non-compete clauses covering stem-cell therapies and biocosmeceuticals.